Nudges Plus Machine Learning Triple Advanced Care Conversations
10.16.2020
Electronic nudges, triggered by a machine-learning algorithm that flags patients at greater mortality risk, increased conversations on end-of-life goals.
Research to transform cancer care
Our mission is to inspire, design, and advance solutions that improve the health and healthcare for patients with cancer. We do so by enhancing patient experience, improving patient outcomes, and increasing the efficiency and productivity of cancer care. We are passionate about catalyzing innovation with our partners.
Our Initiatives
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
Learn more
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
Learn more
We aim to drive high-value cancer care by designing, testing, scaling and evaluating payment models that enhance affordability, access and innovation.
Learn morePC3I News
PC3I Faculty Win $4.9 Million to Improve Uptake of Cancer Care Best Practices
08.05.2020
The National Cancer Institute will fund PC3I and other Penn partners for five years as part of the Cancer Moonshot Initiative.
PC3I Fellow to study racial disparities in new cancer treatment
06.22.2020
Chris Manz, MD, will receive a 2020 Young Investigator Award to study the effect of Medicare's Oncology Care model on disparities in patient access to new cancer therapies.
Media Spotlight
PC3I's Cancer Care @ Home "Tackles a New Frontier"
02.04.2021
In 2020, Penn Medicine delivered cancer treatments to nearly 1500 patients in the comfort of their own homes, propelled by PC3I's Cancer Care @ Home program.
3 Ways to Counter COVID-19's Threat to Community-Based Cancer Care
10.22.2020
Americans take great cancer care for granted. The Covid-19 pandemic is putting this success at risk. In JAMA Oncology, we propose three solutions.
Coronavirus Pandemic Accelerates Move to Cancer Care at Home
10.16.2020
PC3I and its partners launched Cancer Care @ Home in February 2020. One month later, the program had referred 39 patients. The next seven weeks saw a 700% increase in home infusion referrals.